Find Alnodesertib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Art0380, Art-0380, Alnodesertib [inn], W7x77ih95r, Gtpl13731, Bdbm570448
Molecular Formula
C18H24N6O2S
Molecular Weight
388.5  g/mol
InChI Key
JHPDHYAMSPMBIF-MUDIAHQHSA-N
FDA UNII
W7X77IH95R

Alnodesertib
Alnodesertib is an orally bioavailable inhibitor of ataxia telangiectasia and Rad3 related (ATR) kinase, with potential antineoplastic activity. Upon oral administration, alnodesertib selectively targets and inhibits ATR activity and blocks the downstream phosphorylation of the serine/threonine protein kinase checkpoint kinase 1 (CHK1). This prevents ATR-mediated signaling, which results in the inhibition of DNA damage checkpoint activation, the disruption of DNA damage repair, and the induction of tumor cell apoptosis. ATR, a serine/threonine protein kinase upregulated in a variety of cancer cell types, plays a key role in DNA repair, cell cycle progression and survival. It is activated by DNA damage caused during DNA replication-associated stress.
1 2D Structure

Alnodesertib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[4-[(cyclopropyl-methyl-oxo-6-sulfanylidene)amino]-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl]pyridin-2-amine
2.1.2 InChI
InChI=1S/C18H24N6O2S/c1-12-11-26-8-7-24(12)17-10-16(23-27(2,25)14-3-4-14)21-18(22-17)13-5-6-20-15(19)9-13/h5-6,9-10,12,14H,3-4,7-8,11H2,1-2H3,(H2,19,20)/t12-,27+/m1/s1
2.1.3 InChI Key
JHPDHYAMSPMBIF-MUDIAHQHSA-N
2.2 Other Identifiers
2.2.1 UNII
W7X77IH95R
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Art0380

2. Art-0380

3. Alnodesertib [inn]

4. W7x77ih95r

5. Gtpl13731

6. Bdbm570448

7. Us11434233, Example 39b

8. Nsc856901

9. Compound 6 [pmid: 39630604]

10. Nsc-856901

11. Example 39b [wo2019014618a1]

12. Hy-157941

13. Cs-1009739

14. (s)-({2-(2-aminopyridin-4-yl)-6-[(3r)-3-methylmorpholin-4-yl]pyrimidin-4-yl}imino)(cyclopropyl)(methyl)-lambda6-sulfanone

15. 2-(2-amino-4-pyridinyl)-n-[(s)-cyclopropylmethyloxido->>4-sulfanylidene]-6-[ (3r)-3-methyl-4-morpholinyl]-4-pyrimidinamine

16. 2-(2-amino-4-pyridinyl)-n-[(s)-cyclopropylmethyloxido-lambda4-sulfanylidene]-6-[(3r)-3-methyl-4-morpholinyl]-4-pyrimidinamine

17. 4-pyrimidinamine, 2-(2-amino-4-pyridinyl)-n-[(s)-cyclopropylmethyloxido-lambda4-sulfanylidene]-6-[(3r)-3-methyl-4-morpholinyl]-

2.4 Create Date
2020-01-24
3 Chemical and Physical Properties
Molecular Weight 388.5 g/mol
Molecular Formula C18H24N6O2S
XLogP31.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count8
Rotatable Bond Count4
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area115
Heavy Atom Count27
Formal Charge0
Complexity635
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty